Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
David d'AndreaSurena F MatinPeter C BlackFiras G PetrosHomayoun ZargarColin P DinneyMichael S CooksonWassim KassoufMarc A Dall'EraJohn S McGrathJonathan L WrightAndrew C ThorpeTodd M MorganJeffrey M HolzbeierleinTrinity J BivalacquaSrikala S SridharScott NorthDaniel A BarocasYair LotanAndrew J StephensonBas W van RhijnPhilippe E SpiessSiamak DaneshmandShahrokh F ShariatPublished in: BJU international (2020)
Our present findings suggest that the benefit of NAC in UTUC is similar to that found in UCB. These data can be used as a benchmark to contextualise survival outcomes and plan future trial design with NAC in urothelial cancer.
Keyphrases
- urinary tract
- neoadjuvant chemotherapy
- transcription factor
- locally advanced
- lymph node
- papillary thyroid
- sentinel lymph node
- squamous cell
- study protocol
- phase iii
- clinical trial
- electronic health record
- current status
- genome wide analysis
- rectal cancer
- big data
- phase ii
- spinal cord injury
- radiation therapy
- machine learning
- young adults
- high grade